Millions of people who bought DNA tests from genetic testing service 23andme have been urged to delete their personal data ...

Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £15.50.

DNA analysis company 23andme has been in trouble lately: data was breached in a 2023 hack, and this September the entire ...

Nigeria’s manufacturing sector continues to face significant difficulties despite a reported rise in the Purchasing Managers’ ...

Pfizer on Monday won a bid in a London court to invalidate two of GSK's patents relating to a respiratory syncytial virus ...

The news comes as Pfizer is trying to catch up with U.K.-based GlaxoSmithKline (GSK). Its RSV vaccine for adults was approved by the FDA in May. The company is already undergoing priority review with ...

It’s technically you’ll be able to in order to trigger the bonus bullet which have a wild to your all of the 5 reels play 100 Zombies slot, which will make you up to 50 100 percent free spins. However ...

Low uptake in the RSV and COVID vaccine markets is not surprising, an analyst says, and could mean weak earnings for ...

Mpox – formerly known as monkeypox – is rapidly spreading in several African countries, prompting the World Health ...

ViiV’s strategy for CAB LA for PrEP in L&MICs is to maximise rapid access and uptake for populations with highest unmet needs ...

After several high-profile failures, including BMS’ $1.5B breakup with Agenus, anti-TIGIT therapies are generating cautious ...

Pfizer (NYSE:PFE) has reportedly succeeded in getting a U.K. court to invalidate two of GSK’s (NYSE:GSK) patents for its RSV ...